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ABSTRACT. The effects produced in DNA by monofunctional or
interstrand adducts of platinum(II) complexes have been
summarized. The monofunctional adducts destabilize DNA in a
sequence-dependent manner via conformational distortions,
which may have a denaturational character. It has been
suggested that this conformational alteration facilitates in
DNA the formation of the bidentate DNA adducts, whose
formation is associated with a permanent or transient local
denaturation. In addition, DNA interstrand cross-linking by
cis-diamminedichloroplatinum(II) and its trans, isome9
produce in DNA lesions that have quite different
characteristics. It has been suggested that these
differences may have relevance to the distinct antitumor
efficacy of the two platinum isomers.
INTRODUCTION
Platinum cytostatics are widely used for cancer
chemotherapy alone and in combination with other drug (i).
Numerous studies suggest that the cytotoxic action of
platinum drugs is related to its ability to react with
cellular DNA (2-5). The platinum drugs bind to DNA
preferentially to guanine residues at the N(7) position,
producing monofunctional adducts that can subsequently close
to bifunctional lesions (6-8). Most of the structural
information currently available pertains to the intrastrand
cross-links of platinum between adjacent purines. 90 % of
these adducts are found in the reaction of linear DNA with
cis-diamminedichloroplatinum(II) (8,9) {cisplatin, cis-
[Pt(NH3)2CI2]}, which is one of the most effective
anticancer urugs. Therefore, these intrastrand lesions are
believed to represent major DNA adducts of platinum drugs.
Monofunctional lesions, interstrand cross-links and
intrastrand cross-links between two nonadjacent purines are
considered the minor DNA adducts of clinically effective
platinum drugs.
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Clinically ineffective trans isomer of cisplatin
{trans-[Pt(NH3)2Cl2] } does not form intrastrand cross-links
between adjacen purines for sterical reasons (i0). It has
been, therefore, speculated that the latter DNA adducts of
clinically effective cisplatin and its simple analogues are
most likely responsible for antitumor activity of these
drugs. Nevertheless, the DNA lesion (or lesions) of
cisplatin and its simple analogues still remains (or remain)
to be established conclusively.
Chlorodiethylenetriamineplatinum(II) chloride (dien-Pt)
is the monodentate complex, used to afford DNA
monofunctional adducts to simulate the first step of the
bifunctional reaction of cis- or trans-[Pt(NH3) 2C12] and
their simple analogues with DNA. It has been almost
axiomatic that the monofunctional DNA adducts of platinum
complexes do not affect DNA conformation. This view has been
related to antitumor inefficiency of monofunctional platinum
complexes and persists in spite of some results indicating
that the monofunctional platinum(II) adducts change the
conformation of DNA.
The bifunctional platinum complexes can form DNA
interstrand cross-links. Interestingly, the frequency of
interstrand cross-links of cisplatin has been correlated
with its cytotoxicity in several biological systems (ii, 12)
In spite of these results the interstrand cross-links of
platinum complexes are not considered the lesions
responsible for antitumor effect. This view is mainly
derived from the observation that clinically ineffective
tranS-c[.Plstp(aHIn2Cl] forTmhS e
more interstrand cross-links than
does (3) latter speculation is, however,
based on the assumption that both isomers form identical
interstrand DNA lesions. However, DNA interstrand cross-
links of platinum complexes have been studied less
thoroughly so that the latter assumtion has no experimental
support.
In the present paper, we summarize our recent findings
describing (i) distortions produced in DNA by the
monofunctional adducts of platinum complexes and (ii)
characteristics of interstrand cross-links of trans-
[Pt (NH3) 2C12 ]"
RESULTS
Sequence-Dependent Ditort.ns Induced in DNA by
Monofunctional P!atinum.(II) Binding (14,15).
The effects on thermal stability and conformation of
DNA produced by the monofunctional adducts of dien-Pt have
been investigated. Oligodeoxyribonucleotide duplexes of
varying lengths [9 20 base pairs (bp)] and of varying
central trinucleotide sequences were prepared and
characterized that contained site-specific and unique N7-
guanine adduct. Included are adducts at the sequences of
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d(AGC), d(AGT), d(CGA), d(CGT), d(TGA), d(TGC) and d(TGT)
All these monofunctional adducts decrease the melting
temperature (Tm) of the duplexes. This destabilization
effect exhibit’ a sequence-dependent variability. The
highest lowering of Tm is observed for the modified duplexes
containing the central sequence of Py-deoxyriboguanosine-Py
(Py is a pyrimidine deoxyribonucleoside) The
destabilization effect is reduced with decreasing
concentration of Na+. Polarography, circular dichroism,
phenantroline-copper and chemical probes reveal
conformational distortions spreading over several base pairs
around the adduct. The effects of monofunctional
platinum(II) adducts on conformational distortions in DNA
exhibit a similar sequence-dependent variability as on
thermal stability of DNA. The influence of the
monofunctional adduct formed by cis-[Pt(NH) 2CI] on the
stability of the oligonucleotide duplex nas been also
studied. This lesion decreases thermal stability of DNA in
the same way as the adduct of dien-Pt.
The effects on conformation of DNA produced by the
monofunctional adducts of chlorodiethylenetriamine-
platinum II chloride or cis-diamminemonoaquamonochloro-
platinum(II) have been also investigated by means of the
single-strand-specific probe, chloroacetaldehyde (CAA). The
denatured sites to which CAA was bound and that were induced
in DNA by the monofunctional adducts of the platinum
complexes, were characterized by means of the three
experimental approaches. These include measurement of
fluorescence of the plasmid fragment treated with CAA,
analysis of oligonucleotides treated with CAA and cleaved by
piperidine and termination of duplex transcription on
fra
ind
oct
deo
deoxyriboguanos ine-Py. It was suggested
conformational alteration facilitates in DNA
of minor bifunctional adducts
diamminedichloroplatinum (II)
gment of plasmid DNA treated with CAA. The results
icate that the denaturational change preferentially
urs in the base pair containing the monoadducted
xyriboguanosine in the trinucleotide sequence Py-
that this
the formation
of cis-
DNA interstrand cross-links of trans-diamminedichloro-
platinum(II) are preferentially formed between quanine and
complementary cytosine residues (16).
Bases in the opposite strands of DNA cross-linked by
clinically ineffective trans-[Pt(NH)Cl]} have been
identified by means of three experimeta pproaches. These
include HPLC analysis of enzymatic digests of synthetic
oligonucleotide duplexes containing the interstrand cross-
link, footprinting experiments on the interstrand cross-
linked oligonucleotide duplexes and termination of the
duplex transcription on trans-[Pt(NH3)2Cl2]-treated
fragments of plasmid DNA. The results reveal that
deoxyriboguanosine and complementary deoxyribocytidine
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residues are preferential binding sites of trans-
[Pt(NH3) 2CI2] in the interstrand adducts. The kinetics of
the interstrand cross-linking reaction was studied by means
of gel electrophoresis for the cis and trans isomers. The
initial rate was markedly lower in the case of the trans
isomer {tl/ c. ii hr in comparison with 4 hr found for
cis-[Pt(NH C2]}. On the other hand, after 48 hr trans-
[Pt(NH3)2Cl [orms about twice amount of interstrand cross-
links in-linear DNA as compared with the cis isomer after 48
DNA Conformational Chanqe Produced by Site-Specific
Interstrand Cross-Link of trans-Diamminedichloroplatinum(!I)
The DNA distortion produced by the interstrand cross-
link of trans-[Pt(NH3)ClT. ] has been described by means of
gel electrophoresis, -ch-emi-cal probes and molecular mechanics
modeling. Synthetic double-stranded oligodeoxyribonucleo-
tides of varying lengths (19 22 bp) were synthesized that
contained a unique site-specific interstrand cross-link
within their central sequence d(TGCT)/d(AGCT) between
complementary guanine and cytosine residues. We find that
the platinated deoxyriboguanosine residue adopts syn
conformation. The duplex is distorted on both sides of the
cross-link but the bases are still paired. The distortion
introduces some flexibility into the helix. In addition, the
double helix is unwound by proximately 12 and bent
towards the major groove by 260ap.
DXSCUSSXON
The results summarized i.n this paper indicate that the
monofunctional platinum (II) binding induces extensive
conformational distortions in double-helical DNA, which are,
however, qualitatively different from those induced by
bifunctional platinum(II) intrastrand cross-links between
adjacent purine residues. These effects on DNA may have
biological relevance. The latter conclusion is supported by
the observation that monofunctional DNA adducts of platinum
are recognized and repaired in assays with (A) BC
excinuklease even with 2-3 times greater efficiency than the
bifunctional and major adducts of cis-[Pt(NH3)2Cl2] (18).
This paper also summarizes the results of our recent
studies aimed at describing the properties of interstrand
cross-links of trans-[Pt(NH3)2Cl2] (Table I). Table I also
compares the characteristics of these lesions with those
produced by the interstrand cross-links of cis-[Pt(NH3)2Cl2]
described more recently (18,19)
cis- and trans-[Pt(NH3)2Cl2] behave quite differently
with respect to the propertles of DNA interstrand cross-
links. These results may have relevance to the clinical
activity of the platinum drugs. This view is also supported
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by our preliminary results demonstrating that cis-
[Pt (NH) C12] forms preferentially interstrand, not
intrast-ra-nd cross-links in supercoiled DNA at low levels of
its modification.
Table I: Properties of the interstrand cross-links formed in
DNA by cis- or trans-[Pt(NH3)2Cl2]
cis-[Pt(NH3) 2C12 trans- Pt (NH3 2C12 ] Reference
Sites 5 ’ -GC-3
in the \
cross-link: 3 ’ -CG-5 ’ -C-
Bending c. 55 towards
major groove
26 towards
major groove
Unwinding- 0 12
Distortion- Localized at
the platinated
sequence
d (GC)/d (GC)
Nondenaturational,
extending over
c. 4 bp around the
cross-link,
platinated dGuo in
syn conformation,
limited flexibility
of the duplex
Quantity* c. 6 % c. 12 % 16
*) 4 hr tl/2 > ii hr 16 Kinetics tl/2
16, 19
17, 20
17, 20
17, 20
*)In linearized plasmid DNA (2455 bp) at rb 0.001
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